Moving Beyond the Pill: Unlocking Value Through Engaged, Empowered, and Educated Patients
July 30, 2026 | Health Outcomes, Impetus Digital, Market Access, Medical Innovation, PSP, Pharma Strategy, Value-based care, beyond the pill, digital health, digital voice, health innovation, health literacy, patient activation, patient engagement, patient support program, patientcentricity, real world data, treatment adherence
True “beyond-the-pill” strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, and prove value.
The healthcare ecosystem is undergoing a fundamental, albeit gradual and sometimes painfully slow, transformation, shifting from a volume-based model—where prescription volume is prioritized—to one driven by value-based care. In this beyond-the-pill model, emphasis is placed not only on clinical outcomes, but also on real-world patient experiences. At a time when patients demand greater transparency and control over their health journey, patient engagement is no longer a nice-to-have feature or a regulatory checkmark for Pharma—it is a measurable driver of long-term commercial sustainability.
The efficacy of even the most innovative therapies can be fundamentally eroded by poor adherence, low health literacy, and disconnected care pathways. To overcome these issues, creating an environment where the patient is recognized as an active participant in their care journey, empowered to understand and manage their condition, is critical.
Key Elements to Ensure Activated and Involved Patients
1. Shared Decision-making
First and foremost, improved patient activation requires shared decision-making (SDM). SDM can be defined as a collaborative process that merges clinical evidence with the patient’s values, preferences, and lifestyle to select the optimal treatment path. For Pharma, this represents a crucial strategic shift: moving away from a prescriptive model (Pharma → Prescriber → Patient) to a supportive model that enhances HCP-patient dialogue.
This supportive approach can take many shapes, but one of the most straightforward involves developing tools and resources that enable open, balanced HCP-patient conversations. There is no limit to what this can look like, but popular examples include interactive symptom trackers, risk/benefit calculators, eDiaries, and easy-to-use digital decision aids that direct patients to pertinent information based on their individual demographic and clinical characteristics or risk factors, along with printed and digital educational materials covering the topics that matter most to patients. By investing in SDM support tools, Pharma can help ensure patients not only start therapy but also align psychologically with it, setting the foundation for long-term adherence and treatment success.
2. Personalization
The second key factor is radical personalization. Moving beyond basic patient segmentation, true personalization means addressing the patient’s unique and complex barriers and needs. This includes social determinants of health (SDoH), health literacy gaps, logistical hurdles, and/or underlying emotional states…
Read the full article
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Top 10 Most Important Advisor Questions: Messaging and Branding
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in…
Top 10 Most Important Advisor Questions: Key Brand Attributes
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s the first one to keep…
Top 10 Most Important Advisor Questions: Unmet Needs
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s the first one to keep…
Amplifying Opinions of Patients & Caregivers for Higher Quality of Care
Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey…
Expanding Opportunities for Healthcare with “Digital Twins”
Brad Womble, Senior Director of Strategy, Marketing and Mergers & Acquisitions, at Jabil Healthcare dives into several thought-provoking topics, including how insights from “digital twins” can be used to improve…
Top 10 Benefits of Virtual Advisory Boards
As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish…
The 5 W’s of Virtual Patient Engagement
Learn the Who, What, When, Where, and Why (+ How) of virtual patient engagement programs…
How to Increase Engagement During Virtual Events
Tip #4 – How do you plan the agenda for your virtual event?We suggest to invite participant input to build and personalize the engagement.Invite participant input and rethink your agenda…
Engaging KOLs & Gaining Insights in Pharma’s New Normal
Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important…
Mobilizing Agitation Detection in Children with ADHD
Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding…